Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

753
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
753
Classification of Epithelial Tissues: Overview01:22

Classification of Epithelial Tissues: Overview

28.4K
Epithelial tissues are classified according to the shape of the cells and the number of cell layers formed. Cell shapes can be squamous (flattened and thin), cuboidal (square-like, as wide as it is tall), or columnar (rectangular, taller than it is wide). Additionally, the nucleus shape helps identify the type of epithelial cells. Squamous cells have flattened disc-shaped nuclei, cuboidal cells have spherical nuclei, and columnar cells have elongated nuclei.
Based on the number of cell layers,...
28.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

627
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
627
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

427
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
427
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

14.6K
Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
14.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Langerhans cell histiocytosis: an identity crisis.

Medical and pediatric oncology·2001
Same author

Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions.

European journal of cancer (Oxford, England : 1990)·2000
Same author

Behavior of vital and killed autologous pericardium in the descending aorta of sheep.

The Journal of thoracic and cardiovascular surgery·1999
Same author

Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.

Blood·1999
Same author

An unusual histiocytic disorder responding to cyclosporine therapy: a case report.

Journal of pediatric hematology/oncology·1998
Same author

Nosology and pathology of Langerhans cell histiocytosis.

Hematology/oncology clinics of North America·1998

Related Experiment Video

Updated: Mar 17, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

20.6K

Histiocytosis Syndromes Classification, Diagnostic Features and Current Concepts.

B E Favara1

  • 1a I.W.K Hospital for Children, P.O. Box 3070, Halifax, Nova Scotia, Canada, B3J 3G9.

Leukemia & Lymphoma
|July 27, 2016
PubMed
Summary
This summary is machine-generated.

Histiocytosis syndromes are classified based on cell type, including dendritic cells or ordinary histiocytes. This review details Langerhans cell histiocytosis and hemophagocytic syndromes, offering a conceptual framework for understanding these conditions.

Keywords:
HistiocytosisLangerhans cellsactivationdendritic cellshistiocytes

More Related Videos

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry
04:21

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Published on: January 26, 2024

1.6K
Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry
09:15

Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry

Published on: July 26, 2019

10.0K

Related Experiment Videos

Last Updated: Mar 17, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

20.6K
Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry
04:21

Author Spotlight: Efficient Detection of Immune Cell-Infiltration in Cancer Tissues Using Fluorescent Immunohistochemistry

Published on: January 26, 2024

1.6K
Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry
09:15

Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry

Published on: July 26, 2019

10.0K

Area of Science:

  • Pathology
  • Immunology
  • Hematology

Background:

  • Histiocytosis syndromes encompass a spectrum of disorders characterized by the proliferation of histiocytes.
  • These conditions are broadly categorized based on the presence of dendritic cells versus ordinary histiocytes in pathological lesions.
  • Some histiocytosis syndromes, like leukemias and lymphomas, are clearly malignant, while others present diagnostic challenges.

Purpose of the Study:

  • To provide a comprehensive overview of histiocytosis syndromes.
  • To discuss the ontogeny and specific features of Langerhans cell histiocytosis and hemophagocytic syndromes.
  • To present a conceptual framework for classifying and understanding these diverse pathological conditions.

Main Methods:

  • Literature review and synthesis of existing research on histiocytosis syndromes.
  • Detailed discussion of key histiocytosis entities, including Langerhans cell histiocytosis and hemophagocytic syndromes.
  • Conceptual analysis to establish a pathological categorization framework.

Main Results:

  • Histiocytosis syndromes can be differentiated based on the predominant cell type involved (dendritic cells vs. ordinary histiocytes).
  • Langerhans cell histiocytosis and hemophagocytic syndromes represent distinct entities with specific clinical and pathological characteristics.
  • A conceptual context is presented to aid in the classification of histiocytosis syndromes, acknowledging their varied nature.

Conclusions:

  • Understanding the cellular origins and characteristics of histiocytes is crucial for diagnosing and managing histiocytosis syndromes.
  • The classification of histiocytosis syndromes benefits from considering both cellular morphology and clinical behavior.
  • Further research into the ontogeny and pathogenesis of these disorders may refine diagnostic and therapeutic strategies.